1Chu P, Chao TY, Lin YF, et al. Correlation between histomorphometric parameters of bone resorption and serum type 5b tartrate- resistant acid phosphatase in uremic patients on maintenance hemodialysis [ J ]. American Journal of Kidney Diseases, 2003, 41(5):1052- 1059.
2Fletcher S, Jones RG, Rayncr HC, et al. Assessment of renal osteodystrophy in dialysis patients: use of bone alkaline phosphatase, bone mineral density, and parathyroid ultrasound in comparison with bone histology[J]. Nephron, 1997, 75:412 - 419
3Rapisarda F, Granata A, Urso S, et al. Comparative Study of biocheminal markers of bone formation in relation to different dialysis age[J], Ital J Mineral Electrolyte Metab, 1998, 12:27 - 32.
4Carlini RG , Clesca P. The pathogenesis of osteodystrophy after renal transplantation as detected by early alterations in bone remodeling[J ]. Kidney Int, 2003, 11:32 - 36.
5Schmidt - Gayak H, Drueke TB, Ritz E. Non invaslve circulating indicators of bone metabolism in uremia patients:can they replace bone biopsy[J].Nephrol Dial Transplant, 1996, 11:415 - 418.
6Rapisarda F, Granata A, Urso S, et al. Comparative Study of biocheminal markers of bone formation in relation to different dialysis age[J ]. Ital J Mineral Electrolyte Metab, 1998, 12:27 - 32.
7Urenat P, Hiruby M, Ferreira A, et al. Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients[J] .J Am Soc Nephrol, 1996.7:1 - 7.
8Jarava C, Armas JR, Salgueira M, et al. Bone alkaline phosphatase isoenzyme in renal osteodystrophy[J ]. Nephrol Dial Transplant, 1996, 11(3) :43.
9Couttenye MM, D Haese PC, Van Hoof VO, et al. Low serum levels of alkaline phosphatase of bone origin : a good marker of adynamic disease in haemodialysis patients[ J ]. Nephrol Dial Transplant, 1996,11 : 1065 - 1072.
10Couttenye MM, D Haese PC, Deng JT, et al. High prevalence of adynamic bone disease diagnosed by biochemical markers in a wide sample of the European CAPD population[J]. Nephrol Dial Transplant, 1997, 1Z:Z144 - 2150.
6ESTHER A GONZALEZ, KEVIN J MARTIN. Bone and mineral metabolism in chronic renal failure[J]. In Richard J Johnson, John Feehally, eds. Comprehensive Clinical Nephrology, Philadelphia Hacourt Publishers, 2000, 69: 1-11.
7WAHL HG, BANDORSKI M, BANDORSKI D, et al. Tar- trate-resistant acid phosphatase isoform 5b (TRAP): a novel serum marker of bone resorption in haemodialysis patients [J]. XIX Congress of the European Renal Association, Copenhagen.
8CHU P, CHAO TY, LIN YF, et morphometric parameters of bone tartrate-resistant acid nance hemodialysis[J] al. Correlation between histo- resorption and serum type5b phosphatase in uremic patients on mainte- Am J Kidney Dis, 2003,41(5): 1052-1059.
